A novel reloadable autoinjectors (Zibipen) for intramuscular adrenaline injections were designed and developed. This novel AAI was performance tested against some of the leading commercially available autoinjector devices. The results were found to be encouraging to recommend further technological development of the novel autoinjector.

This content is only available via PDF.
You do not currently have access to this content.